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Background
Lynch syndrome is a hereditary predisposition to col-
orectal and endometrial cancers, in addition to cancers
of the stomach, ovary, upper urinary tract, small
bowel, hepatobiliary tract, skin and brain. Lynch syn-
drome is caused by defects in DNA mismatch repair
(MMR), and germline mutations in MLHl, MSH2,
MSH6 and PMS2 as well as high levels of tumor
microsatellite instability (MSI) and loss of MMR pro-
tein expression are frequently found. MMR deficiency
due to loss of MLH1 in tumor tissue may also be due
to gene silencing resulting from hypermethylation of
the MLH1 promoter, which is found in 15% of spora-
dic colorectal and endometrial cancers, and as the sec-
ond “hit” in some individuals with germline mutations
in MLH1. Recently, epigenetic silencing of MLH1 in
normal body cells has been proposed as a novel cause
of predisposition to Lynch syndrome associated
tumors. Twenty five cases of hypermethylation of the
MLH1 promoter in peripheral blood (MLH1 epimuta-
tion) of individuals with young onset colorectal cancer
and/or endometrial cancer have been reported. The
heritability of MLH1 epimutation is still under
investigation.
Methods and results
A 39-year-old woman from the Philippines was diag-
nosed with stage III rectal cancer. Her rectal biopsy
was screened for evidence of MMR deficiency, which
showed high levels of MSI and loss of MLH1 and
PMS2 protein expression. Her mother was diagnosed
with synchronous colon and endometrial cancers at
age 40. She underwent germline mutation analysis of
MLHl which failed to identify a mutation. Her rectal
tumor was screened for MLH1 promoter methylation
and BRAF V600E, which showed hypermethylation of
the MLH1 promoter in both tumor and normal colo-
nic mucosa, and negative BRAF V600E. Analysis of
MLH1 promoter methylation in her peripheral blood
was consistent with MLH1 epimutation. Tissue from
her mother’s colon tumor, endometrial tumor, and
normal body tissue showed high levels of MSI, loss of
MLH1 protein expression, negative BRAF V600E, and
hypermethylation of the MLH1 promoter. Her mother
died from her colon cancer in 1995, thus peripheral
blood was not available. The patient has two unaf-
fected siblings, ages 31 and 35, who have undergone
MLH1 epimutation testing. Neither showed hyper-
methylation of the MLH1 promoter in peripheral
blood.
Conclusions
This case report represents only the third known
instance of maternal, transmission of MLH1 epimuta-
tion. The first was MLH1 epimutation in an unaffected
son of a woman with endometrial, colorectal, and rec-
tal cancers who was found to have MLH1 epimutation.
The second was MLH1 epimutation in the 64-year-old
unaffected mother of a young woman with colorectal
cancer at age 39 and MLH1 epimutation. To our
knowledge, our case is unique in that it represents the
first case of MLH1 epimutation in a clinically affected
mother and daughter, supporting the heritability of
MLH1 epimutation as a rare but important cause of
Lynch syndrome.
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